Skip to content

Soludent

Active
Private limited company·Activiteiten van tandartspraktijken· 3 yrs active
Barelstraat(BOR) 100 ·2880 Bornem, Belgium
KBO/BCE: BE 0801.505.753
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age3 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Soludent is 0.2% (very low). The 2025 annual accounts show equity of €297k and a net result of €148k. Equity is growing by ~88.6% per year across the filed fiscal years. Its solvency ranks better than 35% of 87 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Signals

2 signals · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend
Growing equity
Equity grew over 2023-2025. Profits are largely retained rather than distributed.
View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-06-2026, 58 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 03-06-2026 58 d early 2026-00134726
31-12-2024 31-07-2025 28-05-2025 64 d early 2025-00108695
31-12-2023 31-07-2024 26-04-2024 96 d early 2024-00069869

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2023, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€148k+29.3%
Working capital€287k+101.1%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 03-06-2026 with the NBB · fiscal year 2025 · verkort
€0€100k€200kOperating result 2023: €47k€47kNet result 2023: €24k€24kOperating result 2024: €179k€179kNet result 2024: €115k€115kOperating result 2025: €223k€223kNet result 2025: €148k€148k202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~88.6%/year over 3 fiscal years, indicative, assuming unchanged policy.
€0€200k€400k€600k€800k2026: €428k (€405k - €452k)2027: €560k (€536k - €584k)2028: €691k (€668k - €715k)2023: €34k2024: €148k2025: €297k202320242025202620272028
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (abbreviated schema)
Metric This company Sector median Position in the sector
Solvency 33.4% 56.8%
better than 35% of 87 sector peers
Net result €148k €97k
better than 63% of 87 sector peers
Equity €297k €207k
better than 60% of 87 sector peers
Gross operating margin €223k €237k
better than 48% of 84 sector peers
Total assets €889k €591k
better than 67% of 87 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P35
2023: P15 · n=3452024: P30 · n=3822025: P35 · n=872023 2025
Improving position over 2023-2025 · n=87-382
Net result P63
2023: P33 · n=3392024: P62 · n=3722025: P63 · n=872023 2025
Improving position over 2023-2025 · n=87-372
Equity P60
2023: P28 · n=3452024: P54 · n=3822025: P60 · n=872023 2025
Improving position over 2023-2025 · n=87-382
Gross operating margin P48
2023: P28 · n=3342024: P50 · n=3722025: P48 · n=842023 2025
Improving position over 2023-2025 · n=84-372
Describes the position versus peers, not a forecast.
Net profit
€148k
+29.3% 23-25
Total assets
€889k
+26.6% 23-25
Equity
€297k
+100.0% 23-25
Working capital
€287k
+101.1% 23-25
Income taxes
€43k
+34.8% 23-25
Debt
€77k
+123.6% 23-25
Debt ≤ 1y
€77k
+123.6% 23-25
Current ratio
4.72
-8.1% 23-25
Quick ratio
4.72
-8.1% 23-25
Solvency
33.4%
+57.9% 23-25
Debt / equity
0.26
+11.8% 23-25
ROE
50.0%
-35.3% 23-25
ROA
16.7%
+2.1% 23-25
Figures by fiscal year
Fiscal year2025
Depositverkort
Revenue-
EBITDA-
Net profit€148k
Cash flow-
Staff costs-
Income taxes€43k
Dividends-
Total assets€889k
Equity€297k
Debt€77k
of which ≤ 1y€77k
of which > 1y-
Working capital€287k
Employees (FTE)-
Ratios (computed)
2025
Current ratio4.72
Quick ratio4.72
Working capital ratio32.3%
Solvency33.4%
Debt / equity0.26
Long-term debt ratio-
Interest coverage-
Gross margin-
Net margin-
ROA16.7%
ROE50.0%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€889k
Fixed assets 21/28€525k
Financial fixed assets 28€525k
Current assets 29/58€364k
Investments 50/53€300k
Cash & bank 54/58€63k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€889k
Equity 10/15€297k
Contributions / capital 10/11€10k
Accumulated profits (losses) 14€287k
Provisions & deferred taxes 16€515k
Amounts payable 17/49€77k
Amounts payable within one year 42/48€77k
Income statement
Gross operating margin 9900€223k
Operating result 9901€223k
Financial income 75€1k
Financial charges 65€33k
Result before taxes 9903€191k
Income taxes 67/77€43k
Net result for the period 9904€148k
Result to be appropriated 9905€148k
You're seeing the latest fiscal year only. Unlock 2 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
93 / 100 Excellent
050100
Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap

Establishment units

1 location
Soludent
Barelstraat(BOR) 100, 2880 BornemHandel in eigen onroerend goed
since 20232.344.906.110
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area536 m²
Buildings1
Building footprint129 m²
Volume (LiDAR)35 m³
Tallest building3.6 m

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12362E0028/00K002 Flanders 536 m² 1 · 129 m² 3.6 m
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

2 acts
All acts · 2 updated 5 months ago
2026
06-03-2026 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous
Summary: Fusion proposal
2023
09-05-2023 Incorporation of a new BV Incorporation
Summary: oprichting

Analysis

Snowflake analysis

financial profile on 5 axes
Health93Profitability100Solvency89Growth78Stability94
91 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 93
Profitability 100
Solvency 89
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Activiteiten van tandartspraktijken86230
Primary activity highlighted.
Names & trade names
Legal nameNL Soludent
Registered office
Barelstraat(BOR) 100 bus 1
2880 Bornem, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.